October 2025 • PharmaTimes Magazine • 4-5

Contents

Features

The truly indispensable role of nurses across the modern pharmaverse

Bridging the safety gap in online prescribing of GLP-1 receptor agonists

Impact assessment is the first step to updated ICH GCP compliance

Health systems can maintain trust in a world of rapid AI adoption

Strengthening data integrity in trials with subjective endpoints

Analysis

Smarter tools, smarter solutions – how AI is transforming drug discovery

Innovation on hold – why NICE medicines struggle to reach patients

The Single National Formulary – friend or foe to our industry?

Reframing rare epileptic syndromes

Developing an AI governance strategy

SmartPeople

14.
Access all areas
Decoding the healthcare system – your gateway to local adoption at pace

15.
Beyond approval
Post-marketing pharmacovigilance, streamlined by automation

23.
Doctored truths
Reclaiming trust and tackling misinformation in pharma

34.
Hand over
Software-enhanced drugs are delivering clinically validated outcomes

36.
Movin' on
People, progress and promotion

0
Logo

PharmaTimes

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

editorial@pharmatimes.com
https://pharmatimes.com/
Privacy Policy
Terms of Service

Categories

Explore our inspiring content by topic

PharmaTimes
News
Features
Analysis
SmartPeople

Social Footprints

Follow us on our Social Media Channels

X
linkedin